All lobbying filings

NOVAVAX, INC

NOVAVAX, INC filed a Q3 report for NOVAVAX, INC on October 20, 2025.

Lobbying for NOVAVAX, INC

All filings by NOVAVAX, INC · Everything NOVAVAX, INC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$230,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Maryland

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.